All three FDA-approved sites (abdomen, thigh, upper arm) are equally appropriate
In fact, I would submit that if you only had that, you would be severely handicapped in addressing the complexity and the heterogeneity of what we know the obesity market is, he said in an interview
If you have a physician relationship and insurance coverage for brand-name GLP-1, compare that path
If thats true, it raises a question that extends well beyond any single medication: how many conditions we treat as separate diseases are actually the same disrupted network showing up in different places
Mice rapidly regained weight after treatment cessation, and this was associated with increased food intake, meal size and frequency, carbohydrate oxidation, EE, and activity